Literature DB >> 20661953

Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors.

Yangxin Huang1, Hulin Wu, Edward P Acosta.   

Abstract

Studies on HIV dynamics in AIDS research are very important in understanding the pathogenesis of HIV-1 infection and also in assessing the effectiveness of antiretroviral (ARV) treatment. Viral dynamic models can be formulated through a system of nonlinear ordinary differential equations (ODE), but there has been only limited development of statistical methodologies for inference. This article, motivated by an AIDS clinical study, discusses a hierarchical Bayesian nonlinear mixed-effects modeling approach to dynamic ODE models without a closed-form solution. In this model, we fully integrate viral load, medication adherence, drug resistance, pharmacokinetics, baseline covariates and time-dependent drug efficacy into the data analysis for characterizing long-term virologic responses. Our method is implemented by a data set from an AIDS clinical study. The results suggest that modeling HIV dynamics and virologic responses with consideration of time-varying clinical factors as well as baseline characteristics may be important for HIV/AIDS studies in providing quantitative guidance to better understand the virologic responses to ARV treatment and to help the evaluation of clinical trial design in response to existing therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661953      PMCID: PMC3507994          DOI: 10.1002/bimj.200900173

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  24 in total

1.  Comparing hierarchical models for spatio-temporally misaligned data using the deviance information criterion.

Authors:  L Zhu; B P Carlin
Journal:  Stat Med       Date:  2000 Sep 15-30       Impact factor: 2.373

2.  Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials.

Authors:  H Wu; A A Ding
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

3.  Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity.

Authors:  Yangxin Huang; Susan L Rosenkranz; Hulin Wu
Journal:  Math Biosci       Date:  2003-08       Impact factor: 2.144

4.  A Bayesian approach to parameter estimation in HIV dynamical models.

Authors:  H Putter; S H Heisterkamp; J M A Lange; F de Wolf
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

5.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

6.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

7.  A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients.

Authors:  Line Labbé; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-20       Impact factor: 2.745

8.  Modeling plasma virus concentration during primary HIV infection.

Authors:  M A Stafford; L Corey; Y Cao; E S Daar; D D Ho; A S Perelson
Journal:  J Theor Biol       Date:  2000-04-07       Impact factor: 2.691

9.  A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.

Authors:  Martin Markowitz; Michael Louie; Arlene Hurley; Eugene Sun; Michele Di Mascio; Alan S Perelson; David D Ho
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics.

Authors:  A A Ding; H Wu
Journal:  Math Biosci       Date:  1999-08       Impact factor: 2.144

View more
  10 in total

1.  Modelling the effects of phylogeny and body size on within-host pathogen replication and immune response.

Authors:  Soumya Banerjee; Alan S Perelson; Melanie Moses
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

Review 2.  Mathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Review.

Authors:  Pablo S Rivadeneira; Claude H Moog; Guy-Bart Stan; Cecile Brunet; François Raffi; Virginie Ferré; Vicente Costanza; Marie J Mhawej; Federico Biafore; Djomangan A Ouattara; Damien Ernst; Raphael Fonteneau; Xiaohua Xia
Journal:  Biores Open Access       Date:  2014-10-01

3.  Handling of uncertainty in medical data using machine learning and probability theory techniques: a review of 30 years (1991-2020).

Authors:  Roohallah Alizadehsani; Mohamad Roshanzamir; Sadiq Hussain; Abbas Khosravi; Afsaneh Koohestani; Mohammad Hossein Zangooei; Moloud Abdar; Adham Beykikhoshk; Afshin Shoeibi; Assef Zare; Maryam Panahiazar; Saeid Nahavandi; Dipti Srinivasan; Amir F Atiya; U Rajendra Acharya
Journal:  Ann Oper Res       Date:  2021-03-21       Impact factor: 4.820

4.  Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.

Authors:  Maria J Buzon; Enrique Martin-Gayo; Florencia Pereyra; Zhengyu Ouyang; Hong Sun; Jonathan Z Li; Michael Piovoso; Amy Shaw; Judith Dalmau; Nadine Zangger; Javier Martinez-Picado; Ryan Zurakowski; Xu G Yu; Amalio Telenti; Bruce D Walker; Eric S Rosenberg; Mathias Lichterfeld
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

5.  Experiment Design for Early Molecular Events in HIV Infection.

Authors:  Aditya Jagarapu; LaMont Cannon; Ryan Zurakowski
Journal:  Proc Am Control Conf       Date:  2017-07-03

6.  Occurrence of HIV eradication for preexposure prophylaxis treatment with a deterministic HIV model.

Authors:  Hyeygjeon Chang; Claude Moog; Alessandro Astolfi
Journal:  IET Syst Biol       Date:  2016-12       Impact factor: 1.615

7.  HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics.

Authors:  Rutao Luo; Michael J Piovoso; Javier Martinez-Picado; Ryan Zurakowski
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

8.  Modelling HIV-1 2-LTR dynamics following raltegravir intensification.

Authors:  Rutao Luo; E Fabian Cardozo; Michael J Piovoso; Hulin Wu; Maria J Buzon; Javier Martinez-Picado; Ryan Zurakowski
Journal:  J R Soc Interface       Date:  2013-05-08       Impact factor: 4.118

Review 9.  Clinical management of HIV drug resistance.

Authors:  Karoll J Cortez; Frank Maldarelli
Journal:  Viruses       Date:  2011-04-14       Impact factor: 5.048

Review 10.  Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.

Authors:  Javier Martinez-Picado; Ryan Zurakowski; María José Buzón; Mario Stevenson
Journal:  Retrovirology       Date:  2018-01-30       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.